Consensus ($1.16). Narrows FY25 revenue view to $2.5B-$2.55B from $2.47B-$2.58B, consensus $2.52B. Sees FY25 adjusted EBITDA $263M-$294M.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TDOC:
- Teladoc reports Q2 EPS (19c), consensus (31c)
- Teladoc options imply 9.9% move in share price post-earnings
- Carvana upgraded, Ulta Beauty downgraded: Wall Street’s top analyst calls
- Teladoc initiated with a Neutral at Mizuho
- Teladoc’s Mixed Prospects: Hold Rating Amid Growth in Integrated Care and Challenges in BetterHelp Segment